Waverley Pharma Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was CAD 0.421755 million compared to CAD 0.543389 million a year ago. Net loss was CAD 0.024042 million compared to CAD 0.147355 million a year ago.
For the six months, sales was CAD 0.725662 million compared to CAD 0.903352 million a year ago. Net loss was CAD 0.335032 million compared to CAD 0.321225 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.